Article Text

Download PDFPDF

258 NK gene signature in SLE
  1. Nicole L Fewings1,
  2. Sanjay Swaminathan2,
  3. David Booth3 and
  4. Ming Wei Lin4
  1. 1Westmead Institute for Medical Research
  2. 2Department of Clinical Immunology, Westmead Hospital, Sydney, New South Wales, Australia Department of Medicine, University of Sydney, Sydney, New South Wales, Australia Department of Medicine, Western Sydney University, Sydney, New South Wal
  3. 3Centre for Immunology and Allergy Research, Westmead Institute for Medical Research, University of Sydney, Westmead NSW, Australia
  4. 4Dept of Clinical Immunology and Immunopathology, Westmead Hospital, Westmead NSW 2145; and Faculty of Medicine, Sydney Medical School, University of Sydney, NSW 2000


Background SLE has traditionally been considered a disease of dysregulated B cells and the production of pathogenic autoantibodies. Evidence that other cell types contribute to the observed pathology is being recognised with the advent of a new techniques providing focused avenues of exploration. The aim of this study was to determine which genes are differentially expressed in patients compared to healthy an autoimmune controls. This may then be lead to downstream intracellular signalling pathways and aberrant cytokine production which may contribute to the understanding of the pathogenesis of SLE.

Methods Whole blood RNA was extracted from 46 SLE patients with heterogeneous disease manifestations and at different stages of disease activity, 5 Autoimmune encephalitis and 20 healthy controls. Gene expression was measured using a Nanostring nCounter mRNA expression assay incorporating over 500 immunological genes. Data was analysed using Partek Genomics Suite to identify differentially expressed genes and find pathways that may be of interest to interrogate further in the context of SLE.

Results Gene expression analysis unsurprisingly showed higher expression of interferon-related genes in SLE (MX1, GBP1, IRF7, IFIT2), however we also found that there were genes that were under-expressed. An NK signature with genes such as KLRC2, KLRC1, KLRB1, KLRF1, KLRG1, PRF1 and IL2RB shows the potential value of the approach to discern the important cell types in the development of SLE.

Conclusions The most significantly differentially expressed genes in SLE show an NK signature, with genes that encode activating and inhibitory NK receptors having reduced expression compared to healthy controls. This NK signature recognises a role for this arm of the innate immune response as a unique fingerprint of SLE.

Funding Source(s): None

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.